Macrogenics | 10-K: FY2022 Annual Report
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:27
The FDA has approved AstraZeneca's best-selling drug Imfinzi for the treatment of limited-stage small cell lung cancer.
AZN-1.87%
16:26
Oriental Silicon Valley responds to being listed on the Entity List by the US Department of Commerce: It is expected that the impact on the company is controllable.
16:25
Vietnam will reduce the price of Ron-95 gasoline by 294 dong per liter.